Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication.

Li R, Zhu J, Xie Z, Liao G, Liu J, Chen MR, Hu S, Woodard C, Lin J, Taverna SD, Desai P, Ambinder RF, Hayward GS, Qian J, Zhu H, Hayward SD.

Cell Host Microbe. 2011 Oct 20;10(4):390-400. doi: 10.1016/j.chom.2011.08.013.

2.

Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells.

Hau PM, Deng W, Jia L, Yang J, Tsurumi T, Chiang AK, Huen MS, Tsao SW.

J Virol. 2015 Jan;89(1):652-68. doi: 10.1128/JVI.01437-14.

3.

Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4.

Zhu J, Liao G, Shan L, Zhang J, Chen MR, Hayward GS, Hayward SD, Desai P, Zhu H.

J Virol. 2009 May;83(10):5219-31. doi: 10.1128/JVI.02378-08.

4.

Phosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic Signaling.

Li R, Liao G, Nirujogi RS, Pinto SM, Shaw PG, Huang TC, Wan J, Qian J, Gowda H, Wu X, Lv DW, Zhang K, Manda SS, Pandey A, Hayward SD.

PLoS Pathog. 2015 Dec 29;11(12):e1005346. doi: 10.1371/journal.ppat.1005346.

5.
6.

BRCA1 and Tip60 determine the cellular response to ultraviolet irradiation through distinct pathways.

Kranz D, Dohmesen C, Dobbelstein M.

J Cell Biol. 2008 Jul 14;182(1):197-213. doi: 10.1083/jcb.200712014.

7.

Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation.

Romaker D, Schregel V, Maurer K, Auerochs S, Marzi A, Sticht H, Marschall M.

J Med Chem. 2006 Nov 30;49(24):7044-53.

PMID:
17125257
8.

Activation of DNA Damage Response Pathways during Lytic Replication of KSHV.

Hollingworth R, Skalka GL, Stewart GS, Hislop AD, Blackbourn DJ, Grand RJ.

Viruses. 2015 Jun 5;7(6):2908-27. doi: 10.3390/v7062752.

9.

DNA-damage response pathways triggered by viral replication.

Sinclair A, Yarranton S, Schelcher C.

Expert Rev Mol Med. 2006 Mar 3;8(5):1-11. Review.

10.

The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside.

Liu X, Cohen JI.

Virology. 2015 May;479-480:568-77. doi: 10.1016/j.virol.2015.02.040. Review.

11.

Adeno-associated virus type 2 modulates the host DNA damage response induced by herpes simplex virus 1 during coinfection.

Vogel R, Seyffert M, Strasser R, de Oliveira AP, Dresch C, Glauser DL, Jolinon N, Salvetti A, Weitzman MD, Ackermann M, Fraefel C.

J Virol. 2012 Jan;86(1):143-55. doi: 10.1128/JVI.05694-11.

12.
13.

Overview: cytomegalovirus and the herpesviruses in transplantation.

Fishman JA.

Am J Transplant. 2013 Feb;13 Suppl 3:1-8; quiz 8. doi: 10.1111/ajt.12002. Review.

14.

ORF36 protein kinase of Kaposi's sarcoma herpesvirus activates the c-Jun N-terminal kinase signaling pathway.

Hamza MS, Reyes RA, Izumiya Y, Wisdom R, Kung HJ, Luciw PA.

J Biol Chem. 2004 Sep 10;279(37):38325-30.

15.

Tip60 in DNA damage response and growth control: many tricks in one HAT.

Squatrito M, Gorrini C, Amati B.

Trends Cell Biol. 2006 Sep;16(9):433-42. Review.

PMID:
16904321
16.
17.

A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM.

Sun Y, Jiang X, Chen S, Fernandes N, Price BD.

Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13182-7.

18.

Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro.

Medveczky MM, Sherwood TA, Klein TW, Friedman H, Medveczky PG.

BMC Med. 2004 Sep 15;2:34.

19.

The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host.

Michel D, Mertens T.

Biochim Biophys Acta. 2004 Mar 11;1697(1-2):169-80. Review.

PMID:
15023359
20.

An E2F1-mediated DNA damage response contributes to the replication of human cytomegalovirus.

E X, Pickering MT, Debatis M, Castillo J, Lagadinos A, Wang S, Lu S, Kowalik TF.

PLoS Pathog. 2011 May;7(5):e1001342. doi: 10.1371/journal.ppat.1001342.

Supplemental Content

Support Center